These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 19696057)

  • 1. Both in- and out-hospital worsening of renal function predict outcome in patients with heart failure: results from the Coordinating Study Evaluating Outcome of Advising and Counseling in Heart Failure (COACH).
    Damman K; Jaarsma T; Voors AA; Navis G; Hillege HL; van Veldhuisen DJ;
    Eur J Heart Fail; 2009 Sep; 11(9):847-54. PubMed ID: 19696057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Admission or changes in renal function during hospitalization for worsening heart failure predict postdischarge survival: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF).
    Klein L; Massie BM; Leimberger JD; O'Connor CM; Piña IL; Adams KF; Califf RM; Gheorghiade M;
    Circ Heart Fail; 2008 May; 1(1):25-33. PubMed ID: 19808267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between transient and persistent worsening renal function and mortality in patients with acute decompensated heart failure.
    Aronson D; Burger AJ
    J Card Fail; 2010 Jul; 16(7):541-7. PubMed ID: 20610229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect and clinical prediction of worsening renal function in acute decompensated heart failure.
    Breidthardt T; Socrates T; Noveanu M; Klima T; Heinisch C; Reichlin T; Potocki M; Nowak A; Tschung C; Arenja N; Bingisser R; Mueller C
    Am J Cardiol; 2011 Mar; 107(5):730-5. PubMed ID: 21247523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiorenal interactions: insights from the ESCAPE trial.
    Nohria A; Hasselblad V; Stebbins A; Pauly DF; Fonarow GC; Shah M; Yancy CW; Califf RM; Stevenson LW; Hill JA
    J Am Coll Cardiol; 2008 Apr; 51(13):1268-74. PubMed ID: 18371557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transient worsening of renal function during hospitalization for acute heart failure alters outcome.
    Logeart D; Tabet JY; Hittinger L; Thabut G; Jourdain P; Maison P; Tartiere JM; Solal AC
    Int J Cardiol; 2008 Jul; 127(2):228-32. PubMed ID: 17651843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of impaired renal function on mortality in patients with acutely decompensated chronic heart failure.
    Vaz Pérez A; Otawa K; Zimmermann AV; Stockburger M; Müller-Werdan U; Werdan K; Schmidt HB; Ince H; Rauchhaus M
    Eur J Heart Fail; 2010 Feb; 12(2):122-8. PubMed ID: 20083622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term prognosis of combined chronic heart failure and chronic renal dysfunction after acute stroke.
    Tsagalis G; Bakirtzi N; Spengos K; Vemmou A; Manios E; Xinos K; Vemmos K
    Eur J Heart Fail; 2010 Aug; 12(8):849-54. PubMed ID: 20413394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serial changes in high-sensitive troponin I predict outcome in patients with decompensated heart failure.
    Xue Y; Clopton P; Peacock WF; Maisel AS
    Eur J Heart Fail; 2011 Jan; 13(1):37-42. PubMed ID: 21149316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
    Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
    Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cystatin C, a novel measure of renal function, is an independent predictor of cardiac events in patients with heart failure.
    Arimoto T; Takeishi Y; Niizeki T; Takabatake N; Okuyama H; Fukui A; Tachibana H; Nozaki N; Hirono O; Tsunoda Y; Miyashita T; Shishido T; Takahashi H; Koyama Y; Kubota I
    J Card Fail; 2005 Oct; 11(8):595-601. PubMed ID: 16230262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure and chronic kidney disease.
    Berger AK; Duval S; Manske C; Vazquez G; Barber C; Miller L; Luepker RV
    Am Heart J; 2007 Jun; 153(6):1064-73. PubMed ID: 17540211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhospital and 1-year mortality of patients who develop worsening renal function following acute ST-elevation myocardial infarction.
    Goldberg A; Hammerman H; Petcherski S; Zdorovyak A; Yalonetsky S; Kapeliovich M; Agmon Y; Markiewicz W; Aronson D
    Am Heart J; 2005 Aug; 150(2):330-7. PubMed ID: 16086939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Worsening renal function: what is a clinically meaningful change in creatinine during hospitalization with heart failure?
    Smith GL; Vaccarino V; Kosiborod M; Lichtman JH; Cheng S; Watnick SG; Krumholz HM
    J Card Fail; 2003 Feb; 9(1):13-25. PubMed ID: 12612868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal function in outpatients with chronic heart failure.
    Waldum B; Westheim AS; Sandvik L; Flønaes B; Grundtvig M; Gullestad L; Hole T; Os I
    J Card Fail; 2010 May; 16(5):374-80. PubMed ID: 20447572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morbidity, mortality and economic burden of renal impairment in cardiac intensive care.
    Chew DP; Astley C; Molloy D; Vaile J; De Pasquale CG; Aylward P
    Intern Med J; 2006 Mar; 36(3):185-92. PubMed ID: 16503954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired renal function in patients with ischemic and nonischemic chronic heart failure: association with neurohormonal activation and survival.
    Smilde TD; Hillege HL; Navis G; Boomsma F; de Zeeuw D; van Veldhuisen DJ
    Am Heart J; 2004 Jul; 148(1):165-72. PubMed ID: 15215807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of association between worsening renal function and mortality in heart failure patients treated with nesiritide.
    Miller WL; Kurien S; Warfield KT; Wood CM; Jaffe AS
    Int J Cardiol; 2008 May; 126(2):234-9. PubMed ID: 17482692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of moderate or intensive disease management program on outcome in patients with heart failure: Coordinating Study Evaluating Outcomes of Advising and Counseling in Heart Failure (COACH).
    Jaarsma T; van der Wal MH; Lesman-Leegte I; Luttik ML; Hogenhuis J; Veeger NJ; Sanderman R; Hoes AW; van Gilst WH; Lok DJ; Dunselman PH; Tijssen JG; Hillege HL; van Veldhuisen DJ;
    Arch Intern Med; 2008 Feb; 168(3):316-24. PubMed ID: 18268174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tubular damage and worsening renal function in chronic heart failure.
    Damman K; Masson S; Hillege HL; Voors AA; van Veldhuisen DJ; Rossignol P; Proietti G; Barbuzzi S; Nicolosi GL; Tavazzi L; Maggioni AP; Latini R
    JACC Heart Fail; 2013 Oct; 1(5):417-24. PubMed ID: 24621973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.